Why the study?
Does ticagrelor cause diarrhea in patients with acute coronary syndrome?
Does ticagrelor cause diarrhea in patients with acute coronary syndrome?
Ticagrelor can cause diarrhea as an adverse effect, which is reversible upon switching to an alternative P2Y12 inhibitor like clopidogrel.
Answers are grounded in this paper and cite their sources.
Ticagrelor may cause reversible diarrhea amenable to P2Y12 switch; this case leaves open causality and generalizability.
The P2Y₁₂ inhibitor, ticagrelor, has been shown to prevent thrombotic events and hence, improve morbidity and mortality in patients with acute coronary syndrome following coronary artery stent placement. Despite many clinical benefits, ticagrelor has been associated with several adverse effects, including dyspnea, easy bruising, and gastrointestinal bleeding. We report the case of a 67-year-old patient with an acute coronary artery syndrome requiring percutaneous coronary artery intervention with stenting who developed ticagrelor-induced diarrhea. The patient's ticagrelor medication was replaced with clopidogrel, and his diarrhea completely resolved within one week with no complications observed at his one-month follow-up visit. Clinicians should be aware of this adverse effect of ticagrelor so as to guide them toward possible underlying etiologies and appropriate workup of chronic diarrhea.
No takes yet. Share an insight, caveat, or question.
Alomari et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: